Skip to content


Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Huntsman Wins Declination

Chemical-maker Huntsman Corporation said in an SEC filing last week that the DOJ and SEC won’t take enforcement action against the company for bribes paid in India by employees of a joint venture there.… Continue Reading

In China, Massive Police Sweep For Fake Drugs

China’s public security ministry announced over the weekend that police had detained nearly 2,000 individuals in a sweeping late-July raid on manufacturers of counterfeit drugs.

Fake drug stockpiles worth more than $180 million were seized, including impostor meds for the treatment of diabetes, high blood pressure, and even cancer.… Continue Reading

The FCPA’s Long Shadow

How long should the DOJ and SEC keep self reporting companies on the hook?

For example, in 2005 Tyco International Ltd discovered that subsidiaries and agents might have paid bribes overseas.… Continue Reading